Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Oct 23 424B3 Prospectus supplement
- 18 Sep 23 424B3 Prospectus supplement
- 6 Sep 23 EFFECT Notice of effectiveness
- 5 Sep 23 424B3 Prospectus supplement
- 5 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
23 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 26 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 11 May 23 S-4 Registration of securities issued in business combination transactions
NTBL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of Vascular Biogenics Ltd. of our report dated March 14, 2023 relating to the financial statements of Vascular Biogenics Ltd., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
August 23, 2023 | Certified Public Accountants (Isr.) |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, 146 Derech Menachem Begin St. Tel-Aviv 6492103, Israel,
P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il